CN113398323B - A kind of preparation method and application of sericin adhesive - Google Patents

A kind of preparation method and application of sericin adhesive Download PDF

Info

Publication number
CN113398323B
CN113398323B CN202110740024.0A CN202110740024A CN113398323B CN 113398323 B CN113398323 B CN 113398323B CN 202110740024 A CN202110740024 A CN 202110740024A CN 113398323 B CN113398323 B CN 113398323B
Authority
CN
China
Prior art keywords
sericin
adhesive
preparation
reduced
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110740024.0A
Other languages
Chinese (zh)
Other versions
CN113398323A (en
Inventor
王琳
王征
刘欢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Original Assignee
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Hospital Tongji Medical College Huazhong University of Science and Technology filed Critical Union Hospital Tongji Medical College Huazhong University of Science and Technology
Priority to CN202110740024.0A priority Critical patent/CN113398323B/en
Publication of CN113398323A publication Critical patent/CN113398323A/en
Application granted granted Critical
Publication of CN113398323B publication Critical patent/CN113398323B/en
Priority to PCT/CN2022/098798 priority patent/WO2023273875A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/108Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0015Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0031Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0042Materials resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention belongs to the field of medical biological composite materials, and particularly discloses a preparation method and application of a sericin adhesive, wherein the preparation method of the sericin adhesive comprises the following steps: preparing reduced sericin: dissolving sericin in a tris (2-carboxyethyl) phosphine solution for reduction to obtain a reduced sericin solution; preparation of sericin adhesive: the invention provides a novel preparation method of the sericin adhesive, which is simpler and more environment-friendly; the preparation of the adhesive with underwater adhesion capability by taking sericin as a raw material is realized; the silk gel jelly has good adhesive property and wound repair promoting property.

Description

一种丝胶粘合剂的制备方法及应用A kind of preparation method and application of sericin adhesive

技术领域technical field

本发明属于医用生物复合材料领域,尤其涉及丝胶粘合剂的制备方法及应用。The invention belongs to the field of medical biological composite materials, and particularly relates to a preparation method and application of sericin adhesive.

背景技术Background technique

临床上伤口闭合及创伤软组织重建等涉及重新连接软组织表面的工作一般使用手术缝线进行封闭。但是手术缝合往往会导致额外的创伤、渗漏。因此,寻求容易操作、无需清除的生物可降解组织黏合剂以替代传统的手术缝合线成为当务之急,引发了研究医用粘合剂的热潮。由于水占人体的70%左右,因此大部分植入人体的生物材料都处于湿润环境,这就要求粘合剂需具备水下粘合能力。人体环境中生物材料粘附失败的原因可归结为几个因素。首先,水分子可以在生物材料与组织之间的界面上形成薄薄的水合作用层,从而阻止生物材料上的粘附基团接触组织表面。其次,水分子很容易破坏生物材料与组织之间的非共价粘合相互作用。另外,吸水后生物材料(例如水凝胶)的溶胀或收缩也会削弱它们对组织的粘附力。因此,开发能够在潮湿条件下实现有效粘附的生物材料具有重大意义。Surgical sutures are often used for clinical work involving reconnection of soft tissue surfaces, such as wound closure and trauma soft tissue reconstruction. But surgical suturing often results in additional trauma and leakage. Therefore, it is imperative to seek biodegradable tissue adhesives that are easy to handle and do not require removal to replace traditional surgical sutures, which has led to an upsurge in the study of medical adhesives. Since water accounts for about 70% of the human body, most of the biomaterials implanted in the human body are in a humid environment, which requires the adhesive to have underwater bonding ability. The reasons for the failure of biomaterial adhesion in the human environment can be attributed to several factors. First, water molecules can form a thin layer of hydration at the interface between the biomaterial and tissue, preventing adhesive groups on the biomaterial from contacting the tissue surface. Second, water molecules can easily disrupt non-covalent adhesive interactions between biomaterials and tissues. In addition, swelling or shrinking of biomaterials (eg, hydrogels) after water absorption can also weaken their adhesion to tissues. Therefore, it is of great significance to develop biomaterials that can achieve effective adhesion under humid conditions.

丝胶是包裹在丝素纤维表层的一种天然大分子蛋白,长期以来由于人们对丝胶认识的不足和研究的局限性,导致每年有大量丝胶在缫丝工业中被当作废物处理,浪费了大量宝贵的天然资源,并对环境造成了严重的污染。近年来,如CN 111188194等中展示,丝胶具有良好的生物性能如低免疫原性、生物可降解性、抗氧化性、细胞黏附性,因而丝胶对皮肤组织、血管组织、骨组织损伤具有优良的修复效果。Sericin is a natural macromolecular protein wrapped on the surface of silk fibroin. For a long time, due to the lack of people's understanding of sericin and the limitation of research, a large amount of sericin is treated as waste in the silk reeling industry every year. It wastes a lot of precious natural resources and causes serious pollution to the environment. In recent years, as shown in CN 111188194, etc., sericin has good biological properties such as low immunogenicity, biodegradability, anti-oxidation, and cell adhesion, so sericin has good effects on skin tissue, vascular tissue, and bone tissue damage. Excellent repair effect.

在海洋中,贻贝可以在不断受到海浪袭击的情况下牢固地粘附在岩石等各种基质上,为水下粘合剂的开发提供了灵感。贻贝足蛋白中的多巴基团DOPA是被认为贻贝粘附的关键,它通过非共价相互作用(包括氢键,金属配位,π-π相互作用和阳离子-π相互作用)实现粘附。为了克服水对粘合剂的破坏作用,受海洋贻贝启发,研究人员在高分子链中引入DOPA基团来制备粘合剂,但是粘合剂的制备需要复杂的预改性过程或有毒的氧化剂/金属离子,限制了这类粘合剂的潜在生物应用。因此,如何制备生物相容性较好的水下粘合剂是亟待解决的问题。In the ocean, mussels can adhere strongly to various substrates, such as rocks, under constant exposure to waves, inspiring the development of underwater adhesives. The dopa group DOPA in mussel podins is thought to be critical for mussel adhesion, which is achieved through non-covalent interactions including hydrogen bonding, metal coordination, π-π interactions and cation-π interactions Adhesion. In order to overcome the destructive effect of water on the adhesive, inspired by marine mussels, the researchers introduced DOPA groups into the polymer chain to prepare the adhesive, but the preparation of the adhesive requires a complex pre-modification process or toxic Oxidant/metal ions, limiting the potential biological applications of this type of adhesive. Therefore, how to prepare underwater adhesives with better biocompatibility is an urgent problem to be solved.

发明内容SUMMARY OF THE INVENTION

针对上述问题,本发明提供水下丝胶粘合剂的制备方法及应用,通过调节粘合剂成份的亲疏水平衡促进组织表面排水,主要解决了现有粘合剂不具备水下粘合能力,粘合强度弱,生物相容性差等问题。In view of the above-mentioned problems, the present invention provides a preparation method and application of an underwater sericin adhesive. By adjusting the hydrophilic and hydrophobic balance of the adhesive components, the drainage of the tissue surface is promoted, which mainly solves the problem that the existing adhesive does not have the ability of underwater adhesion. Weak adhesive strength, poor biocompatibility and other issues.

为了解决上述问题,本发明采用如下技术方案:In order to solve the above problems, the present invention adopts the following technical solutions:

丝胶粘合剂的制备方法,包括下述步骤A preparation method of sericin adhesive, comprising the following steps

还原丝胶制备:丝胶粉干溶于三(2-羧乙基)膦的4-羟乙基哌嗪乙磺酸缓冲液中还原,获得还原丝胶溶液;Preparation of reduced sericin: sericin powder is dry dissolved in tris(2-carboxyethyl)phosphine and reduced in 4-hydroxyethylpiperazineethanesulfonic acid buffer to obtain reduced sericin solution;

丝胶粘合剂制备:还原丝胶溶液与单宁酸溶液混合,充分反应后获得丝胶粘合剂;Preparation of sericin adhesive: The reduced sericin solution is mixed with the tannic acid solution, and the sericin adhesive is obtained after fully reacting;

一种方式中,还包括In one way, it also includes

丝胶粉干制备:蚕茧置于Na2CO3溶液,搅拌得胶丝溶液,除杂,透析,冻干。Dry preparation of sericin powder: silkworm cocoons are placed in Na 2 CO 3 solution, stirred to obtain glue silk solution, impurity removal, dialysis, and freeze-drying.

一种方式中,还原丝胶制备中:In one way, in the preparation of reduced sericin:

4-羟乙基哌嗪乙磺酸缓冲液pH为7.0-7.4,4-Hydroxyethylpiperazineethanesulfonic acid buffer pH 7.0-7.4,

三(2-羧乙基)膦以1-30g/mL比例溶于4-羟乙基哌嗪乙磺酸缓冲液Tris(2-carboxyethyl)phosphine was dissolved in 4-hydroxyethylpiperazine ethanesulfonic acid buffer at a ratio of 1-30 g/mL

一种方式中,还原丝胶溶液制备:丝胶溶于三(2-羧乙基)膦的4-羟乙基哌嗪乙磺酸缓冲液中,制成浓度10-30%(W/V)还原丝胶溶液。In one way, the preparation of reduced sericin solution: sericin is dissolved in tris(2-carboxyethyl) phosphine in 4-hydroxyethylpiperazine ethanesulfonic acid buffer to make a concentration of 10-30% (W/V ) reduced sericin solution.

丝胶粉干以0.01-0.3g/mL比例溶于三(2-羧乙基)膦溶液,The dry sericin powder is dissolved in tris(2-carboxyethyl)phosphine solution at the ratio of 0.01-0.3g/mL,

丝胶粉干与三(2-羧乙基)膦质量比为1/20-1/30,The mass ratio of dry sericin powder to tris(2-carboxyethyl)phosphine is 1/20-1/30,

一种方式中,丝胶粘合剂制备中,还原丝胶溶液、单宁酸溶液按(1-1.5):(1-2)体积比混合。In one method, in the preparation of the sericin adhesive, the reduced sericin solution and the tannic acid solution are mixed in a volume ratio of (1-1.5):(1-2).

一种方式中,丝胶粘合剂制备中:In one way, the sericin adhesive is being prepared:

单宁酸溶液浓度为0.05-0.5g/mL。The concentration of tannic acid solution is 0.05-0.5g/mL.

一种方式中,丝胶粘合剂制备中,还原丝胶溶液与单宁酸溶液混合,充分反应后获得丝胶粘合剂。In one way, in the preparation of the sericin adhesive, the reduced sericin solution is mixed with the tannic acid solution and fully reacted to obtain the sericin adhesive.

本发明的有益效果是:The beneficial effects of the present invention are:

提供了一种较新的丝胶粘合剂的制备方法,更加简单、环保;实现以丝胶作为原料制备粘合剂;丝胶粘合剂具有较好粘合性能和促创面修复性能。A relatively new preparation method of sericin adhesive is provided, which is simpler and environmentally friendly; the adhesive is prepared by using sericin as a raw material; and the sericin adhesive has good adhesion performance and wound surface repairing performance.

附图说明Description of drawings

图1为丝胶粘合剂的各项性能展示图;Figure 1 is the performance display diagram of the sericin adhesive;

图2为丝胶粘合剂的粘合性能展示图;Fig. 2 is a graph showing the adhesion performance of sericin adhesive;

图3为丝胶粘合剂对生物组织的粘合性能展示图;Figure 3 is a graph showing the adhesion performance of sericin adhesive to biological tissue;

图4为丝胶粘合剂体内促愈合性能展示图。Figure 4 is a graph showing the in vivo healing-promoting performance of sericin adhesive.

图5为丝胶粘合剂体内降解展示图。Figure 5 is a graph showing the degradation of sericin adhesive in vivo.

图6为丝胶粘合剂生物相容性展示图。Figure 6 is a graph showing the biocompatibility of sericin adhesive.

具体实施方式Detailed ways

下面结合附图对本发明做进一步说明:The present invention will be further described below in conjunction with the accompanying drawings:

丝胶粘合剂的制备方法,包括下述步骤A preparation method of sericin adhesive, comprising the following steps

还原丝胶制备:丝胶粉干溶于三(2-羧乙基)膦的4-羟乙基哌嗪乙磺酸缓冲液中还原,获得还原丝胶溶液;Preparation of reduced sericin: sericin powder is dry dissolved in tris(2-carboxyethyl)phosphine and reduced in 4-hydroxyethylpiperazineethanesulfonic acid buffer to obtain reduced sericin solution;

丝胶粘合剂制备:还原丝胶溶液与单宁酸溶液混合,充分反应后获得丝胶粘合剂;Preparation of sericin adhesive: The reduced sericin solution is mixed with the tannic acid solution, and the sericin adhesive is obtained after fully reacting;

一种方式中,还包括In one way, it also includes

丝胶粉干制备:蚕茧置于Na2CO3溶液,搅拌得胶丝溶液,除杂,透析,冻干。Dry preparation of sericin powder: silkworm cocoons are placed in Na 2 CO 3 solution, stirred to obtain glue silk solution, impurity removal, dialysis, and freeze-drying.

一种方式中,还原丝胶制备中:In one way, in the preparation of reduced sericin:

4-羟乙基哌嗪乙磺酸缓冲液pH为7.0-7.4,4-Hydroxyethylpiperazineethanesulfonic acid buffer pH 7.0-7.4,

三(2-羧乙基)膦以1-30g/mL比例溶于4-羟乙基哌嗪乙磺酸缓冲液Tris(2-carboxyethyl)phosphine was dissolved in 4-hydroxyethylpiperazine ethanesulfonic acid buffer at a ratio of 1-30 g/mL

丝胶粉干以0.01-0.3g/mL比例溶于三(2-羧乙基)膦溶液,The dry sericin powder is dissolved in tris(2-carboxyethyl)phosphine solution at the ratio of 0.01-0.3g/mL,

丝胶粉干与三(2-羧乙基)膦质量比为1/20-1/30,The mass ratio of dry sericin powder to tris(2-carboxyethyl)phosphine is 1/20-1/30,

一种方式中,还原丝胶溶液制备:丝胶溶于三(2-羧乙基)膦的4-羟乙基哌嗪乙磺酸缓冲液中,制成浓度10-20%(W/V)还原丝胶溶液。In one way, the preparation of reduced sericin solution: sericin is dissolved in tris(2-carboxyethyl) phosphine in 4-hydroxyethylpiperazine ethanesulfonic acid buffer to make a concentration of 10-20% (W/V ) reduced sericin solution.

一种方式中,丝胶粘合剂制备中,还原丝胶溶液、单宁酸溶液按(1-1.5):(1-2)体积比混合。In one method, in the preparation of the sericin adhesive, the reduced sericin solution and the tannic acid solution are mixed in a volume ratio of (1-1.5):(1-2).

一种方式中,丝胶粘合剂制备中:In one way, the sericin adhesive is being prepared:

单宁酸溶液浓度为0.05-0.5g/mL。The concentration of tannic acid solution is 0.05-0.5g/mL.

一种方式中,丝胶粘合剂制备中,还原丝胶溶液与单宁酸溶液混合,充分反应后获得丝胶粘合剂。In one way, in the preparation of the sericin adhesive, the reduced sericin solution is mixed with the tannic acid solution and fully reacted to obtain the sericin adhesive.

丝胶粘合剂的一些物性特征如图1中展示。Some physical properties of the sericin adhesive are shown in Figure 1.

下面对其中部分制备方法做进一步说明:Some of the preparation methods are further described below:

1)丝胶的提取1) Extraction of sericin

称取蚕茧(家蚕蚕茧(白玉、皓月),棹蚕茧(A.mylitta)或蓖麻蚕茧等),将其剪成碎片,清洗干净,去除水分。Weigh silkworm cocoons (Bombyx mori cocoons (Baiyu, Haoyue), A. mylitta or castor cocoons, etc.), cut them into pieces, wash them, and remove moisture.

每克蚕茧加入20mL的0.02mol/L Na2CO3水溶液,在100℃条件下搅拌1小时,使丝胶溶解,得到丝胶溶液。Add 20 mL of a 0.02 mol/L Na 2 CO 3 aqueous solution per gram of silkworm cocoons, and stir at 100° C. for 1 hour to dissolve the sericin to obtain a sericin solution.

离心去除丝胶溶液中的杂质成分,透析12~72小时,获得澄清丝胶溶液,冻干后得到丝胶粉末。The impurity components in the sericin solution are removed by centrifugation, dialyzed for 12-72 hours to obtain a clear sericin solution, and the sericin powder is obtained after lyophilization.

2)还原丝胶的制备2) Preparation of reduced sericin

将步骤1)中得到的丝胶或商品化的丝胶以0.1g/mL的比例溶解于1-10mL的三(2-羧乙基)膦溶液中(4-羟乙基哌嗪乙磺酸缓冲液,pH7.0~7.4)中,反应30分钟得到还原丝胶蛋白溶液。The sericin obtained in step 1) or commercialized sericin was dissolved in 1-10 mL of tris(2-carboxyethyl)phosphine solution (4-hydroxyethylpiperazineethanesulfonic acid) at a ratio of 0.1 g/mL. buffer, pH 7.0-7.4), react for 30 minutes to obtain a reduced sericin solution.

3)单宁酸溶液的配制3) Preparation of tannic acid solution

称取1g单宁酸溶于10mL ddH2O中,制成浓度为10%(W/V)的单宁酸溶液Weigh 1 g of tannic acid and dissolve it in 10 mL of ddH 2 O to make a tannic acid solution with a concentration of 10% (W/V).

4)丝胶粘合剂的制备4) Preparation of sericin adhesive

按体积比1:1将还原丝胶溶液与过单宁酸溶液混合,充分搅拌得到丝胶粘合剂,取出后用ddH2O清洗五次得到所述丝胶粘合剂。The reduced sericin solution is mixed with the pertannic acid solution in a volume ratio of 1:1, fully stirred to obtain a sericin adhesive, and after being taken out, washed with ddH 2 O for five times to obtain the sericin adhesive.

除了DOPA基团外,贻贝足蛋白中还含有部分疏水氨基酸,暴露出的疏水基团通过疏水作用排出表面水分子,从而实现持续水下粘合。丝胶蛋白分子骨架中存在少量富含二硫键的疏水氨基酸(半胱/胱氨酸),基于上述理论,我们利用还原剂打开丝胶蛋白中的二硫键,暴露出疏水氨基酸,进一步与单宁酸通过氢键、范德华力和疏水相互作用形成丝胶粘合剂。通过促进表面排水,调节亲水-疏水平衡来实现有效的水下粘附。In addition to the DOPA group, the mussel foot protein also contains some hydrophobic amino acids, and the exposed hydrophobic groups expel surface water molecules through hydrophobic interaction, thereby achieving continuous underwater adhesion. There are a small amount of disulfide-rich hydrophobic amino acids (cysteine/cystine) in the sericin molecular backbone. Based on the above theory, we use a reducing agent to open the disulfide bonds in sericin to expose the hydrophobic amino acids, which further interact with the sericin. Tannins form sericin adhesives through hydrogen bonding, van der Waals forces, and hydrophobic interactions. Efficient underwater adhesion is achieved by promoting surface drainage and regulating the hydrophilic-hydrophobic balance.

在后续的研究中,我们在体外及体内测试了该丝胶粘合剂的粘合性能及促修复性能,发现该材料具有较好的组织粘合性能,可有效促进创面的修复,同时具有良好的生物相容性。In the follow-up research, we tested the adhesive properties and repair-promoting properties of the sericin adhesive in vitro and in vivo, and found that the material has good tissue adhesion properties, which can effectively promote the repair of wounds. Biocompatibility.

具体实施例如下Specific examples are as follows

实施例1丝胶粘合剂的制备Example 1 Preparation of sericin adhesive

步骤1)丝胶的提取Step 1) Extraction of sericin

1.称取蚕茧(家蚕蚕茧(白玉、皓月),棹蚕茧(A.mylitta)或蓖麻蚕茧等),将其剪成碎片,用ddH2O清洗干净,3500rpm离心5分钟去除水分;1. Weigh silkworm cocoons (Bombyx mori cocoons (Bombyx mori, Haoyue), A. mylitta or castor cocoons, etc.), cut them into pieces, clean them with ddH 2 O, and centrifuge at 3500rpm for 5 minutes to remove moisture;

2.每克蚕茧加入20mL的0.02mol/L Na2CO3水溶液,置于恒温水浴锅在100℃条件下搅拌1小时,使丝胶溶解,得到丝胶溶液;2. Add 20mL of 0.02mol/L Na 2 CO 3 aqueous solution per gram of silkworm cocoons, place in a constant temperature water bath and stir at 100°C for 1 hour to dissolve sericin to obtain sericin solution;

3.将得到的丝胶溶液转入50mL离心管中,3500rpm离心5分钟去除丝胶溶液中的杂质成分,得到澄清溶液;3. Transfer the obtained sericin solution into a 50 mL centrifuge tube, and centrifuge at 3500 rpm for 5 minutes to remove impurities in the sericin solution to obtain a clear solution;

4.将澄清溶液转入分子截留量为3500Da的透析袋中,于ddH2O中透析72小时,慢速搅拌,每隔6小时换一次水;4. Transfer the clear solution into a dialysis bag with a molecular cut-off of 3500Da, dialyze it in ddH 2 O for 72 hours, stir at a slow speed, and change water every 6 hours;

5.将丝胶溶液转入50mL离心管中,置于液氮中速冻5分钟后放入冻干机,冻干后得到丝胶粉末,放入-20℃冰箱保存备用。5. Transfer the sericin solution to a 50mL centrifuge tube, put it in liquid nitrogen for quick freezing for 5 minutes, and then put it into a freeze dryer. After freeze-drying, the sericin powder is obtained, which is stored in a -20°C refrigerator for later use.

步骤2)还原丝胶的制备Step 2) Preparation of reduced sericin

将步骤1)中得到的丝胶以0.1g/mL的比例溶解于1-10mL的三(2-羧乙基)膦溶液中(4-羟乙基哌嗪乙磺酸缓冲液,pH 7.0~7.4)中,反应30分钟得到还原丝胶蛋白溶液;The sericin obtained in step 1) was dissolved in 1-10 mL of tris(2-carboxyethyl) phosphine solution (4-hydroxyethylpiperazine ethanesulfonic acid buffer, pH 7.0~ 7.4), react for 30 minutes to obtain a reduced sericin solution;

步骤3)单宁酸溶液的配制Step 3) Preparation of tannic acid solution

称取1g单宁酸溶于10mL ddH2O中,制成浓度为10%(W/V)的单宁酸溶液;Weigh 1 g of tannic acid and dissolve it in 10 mL of ddH 2 O to prepare a tannic acid solution with a concentration of 10% (W/V);

步骤4)丝胶粘合剂的制备Step 4) Preparation of sericin adhesive

按体积比1:1将还原丝胶溶液与过单宁酸溶液混合,充分搅拌得到丝胶粘合剂,取出后用ddH2O清洗五次得到所述丝胶粘合剂。The reduced sericin solution is mixed with the pertannic acid solution in a volume ratio of 1:1, fully stirred to obtain a sericin adhesive, and after being taken out, washed with ddH 2 O for five times to obtain the sericin adhesive.

实施例2还原丝胶及丝胶粘合剂表征检测Example 2 Characterization and detection of reduced sericin and sericin adhesive

图1中A图为还原剂三(2-羧乙基)膦处理前后丝胶蛋白的溶液,B、C、D分别为丝胶和还原丝胶的巯基含量、紫外吸收光谱、zeta电位。In Figure 1, picture A is the solution of sericin before and after treatment with reducing agent tris(2-carboxyethyl) phosphine, and B, C, and D are the sulfhydryl content, UV absorption spectrum, and zeta potential of sericin and reduced sericin, respectively.

观察如图1中A所示,还原剂处理后丝胶蛋白溶液变浑浊,B图显示还原丝胶分子中巯基含量显著增加,说明还原剂三(2-羧乙基)膦处理引起丝胶蛋白分子中二硫键断裂,导致巯基含量增加,图1中C图显示还原丝胶溶液在280nm处疏水氨基酸的吸收峰增强,进一步说明二硫键断裂引起蛋白中疏水氨基酸外翻。图1中D图显示还原剂处理引起丝胶蛋白溶液表明zeta电位由负变正,说明疏水氨基酸外翻导致蛋白表面电位变化。As shown in Fig. 1 A, the sericin solution became cloudy after the reducing agent treatment, and the sulfhydryl group content in the reduced sericin molecule was significantly increased in Fig. B, indicating that the reducing agent tris(2-carboxyethyl) phosphine treatment caused sericin The disulfide bond in the molecule is broken, resulting in an increase in the content of sulfhydryl groups. Figure C in Figure 1 shows that the absorption peak of the hydrophobic amino acid in the reduced sericin solution is enhanced at 280 nm, which further indicates that the disulfide bond breakage causes the hydrophobic amino acid in the protein to turn out. Panel D in Figure 1 shows that the sericin solution caused by reducing agent treatment shows that the zeta potential changes from negative to positive, indicating that the eversion of hydrophobic amino acids leads to changes in the surface potential of the protein.

图1中E为丝胶粘合剂的制备过程,F图为制备的丝胶粘合剂(rSer-TA)实物图,显示丝胶粘合剂在拉伸时有拉丝现象。图1中G为丝胶粘合剂的傅里叶红外光谱图(FTIR),与丝胶蛋白相比,丝胶粘合剂在1658cm-1的酰胺I键移至1655cm-1,这表明还原剂处理不会引起丝胶蛋白二级结构的变化,图1中H和I为丝胶蛋白和丝胶粘合剂的X射线光电子能谱图(XPS),结果显示丝胶中二硫键(HSSH)的峰位于164.2eV,而丝胶粘合剂rSer-TA中S—C=O结构峰位于168.3eV,这表明单宁酸中部分氧化的酚醛结构与丝胶蛋白中的巯基发生反应,形成迈克尔型加合物,以上结果说明该丝胶粘合剂是基于分子间相互作用和部分共价作用形成的。In Figure 1, E is the preparation process of the sericin adhesive, and Figure F is the actual picture of the prepared sericin adhesive (rSer-TA), which shows that the sericin adhesive has a wire drawing phenomenon during stretching. G in Fig. 1 is the Fourier transform infrared spectroscopy (FTIR) of sericin adhesive. Compared with sericin, the amide I bond of sericin adhesive at 1658 cm -1 is shifted to 1655 cm -1 , which indicates that the reducing agent treatment It will not cause changes in the secondary structure of sericin. H and I in Figure 1 are X-ray photoelectron spectroscopy (XPS) of sericin and sericin adhesive. The results show that the disulfide bond (HSSH) in sericin The peak is located at 164.2 eV, while the peak of the S—C=O structure in the sericin adhesive rSer-TA is located at 168.3 eV, which indicates that the partially oxidized phenolic structure in the tannic acid reacts with the sulfhydryl group in sericin to form a Michael-type compound. The above results indicate that the sericin adhesive is formed based on intermolecular interactions and partial covalent interactions.

实施例3丝胶粘合剂的水下粘合能力测试Example 3 Test of underwater adhesion ability of sericin adhesive

一、实验过程1. The experimental process

1.准备1cm*3cm陶瓷片,将还原丝胶粘合剂和非还原丝胶粘合剂分别涂抹在陶瓷片上,随后放入水中;1. Prepare a 1cm*3cm ceramic sheet, apply the reduced sericin adhesive and the non-reduced sericin adhesive on the ceramic sheet respectively, and then put it in water;

2.将100g砝码放置到陶瓷片上,等待30s,待其粘合;2. Place the 100g weight on the ceramic piece, wait for 30s, and wait for it to bond;

3.提起砝码,观察界面粘合情况及陶瓷片脱落情况。3. Lift the weight and observe the bonding of the interface and the falling off of the ceramic sheet.

二、结果分析2. Analysis of the results

如图2A所示,提起砝码时,还原丝胶粘合剂将砝码和陶瓷片粘合在一起,而且流水冲击30s后二者仍然粘合在一起(图2B),说明还原丝胶粘合剂具有水下粘合能力。而非还原丝胶粘合剂无法将砝码和陶瓷片粘合,说明其不具备水下粘合能力。以上结果说明还原丝胶粘合剂由于具有一定的疏水基团有助于增强其水下粘合性能。As shown in Figure 2A, when the weight was lifted, the reduced sericin adhesive bonded the weight and the ceramic sheet together, and the two were still bonded together after 30s of water impact (Figure 2B), indicating that the reduced sericin adhesive Has underwater bonding ability. The non-reduced sericin adhesive cannot bond the weight and the ceramic sheet, indicating that it does not have the ability to bond underwater. The above results indicate that the reduced sericin adhesive has a certain hydrophobic group to enhance its underwater adhesive performance.

实施例4丝胶粘合剂体外粘合能力测试Example 4 In vitro adhesion ability test of sericin adhesive

一、实验过程1. The experimental process

用还原丝胶粘合剂粘合两块基底片(聚甲基丙烯酸甲酯PMMA片,铁片,硅片,陶瓷片),待固化30min后用力学拉伸仪检测粘合剂的粘合强度。Two base sheets (polymethyl methacrylate PMMA sheet, iron sheet, silicon sheet, ceramic sheet) were bonded with reduced sericin adhesive, and the adhesive strength of the adhesive was tested with a mechanical tensile tester after curing for 30 minutes.

二、结果分析2. Analysis of the results

1.如图2中C-D所示,丝胶粘合剂粘合的基底片粘合强度均达到0.5MPa以上,表现出很强的粘合强度。1. As shown in C-D in Figure 2, the adhesive strength of the substrate sheets bonded with sericin adhesives all reached more than 0.5MPa, showing a strong adhesive strength.

2.如图2中E-F所示,随着单宁酸含量增加,丝胶粘合剂的粘合强度呈递增形式。2. As shown in Figure 2, E-F, the bond strength of the sericin adhesive increases with increasing tannin content.

实施例5丝胶粘合剂对组织粘合能力测试Example 5 Test of the adhesive ability of sericin adhesive to tissue

一、实验过程1. The experimental process

1.准备猪皮,小肠和大肠组织裁剪成一定尺寸;1. Prepare pig skin, cut small intestine and large intestine tissue to a certain size;

2.将还原丝胶粘合剂和非还原丝胶粘合剂分别涂抹在三种组织表面,通过扭转组织观察粘合剂的粘合强度,并进一步将组织贴附在基底片上检测力学粘合强度;2. Apply the reduced sericin adhesive and the non-reduced sericin adhesive on the surfaces of the three tissues respectively, observe the adhesive strength of the adhesive by twisting the tissues, and further attach the tissues to the base sheet to test the mechanical adhesive strength;

3.将粘合的组织浸泡在水中30min,取出后通过扭转观察粘合剂的粘合强度,并进一步检测力学粘合强度;3. Soak the bonded tissue in water for 30min, take it out, observe the bond strength of the adhesive by twisting, and further test the mechanical bond strength;

二、结果分析2. Analysis of the results

如图3A所示,还原丝胶粘合剂粘合的组织在大力扭转时仍然粘附在组织表面,浸水30min后粘合剂仍保留在组织表面,且在大力扭转时不会脱落。图3B显示非还原粘合剂粘合的组织在大力扭转时显示出有缝隙存在,浸水30min后粘合剂脱落。以上结果说明疏水基团外翻导致还原丝胶粘合剂对组织的粘合强度更高,进一步说明调节粘合剂的亲疏水平衡可调节其水下粘合能力。As shown in Figure 3A, the tissue bonded by the reduced sericin adhesive still adhered to the tissue surface when twisted vigorously, and the adhesive remained on the surface of the tissue after immersion in water for 30 min, and did not fall off when twisted vigorously. Figure 3B shows that the tissue bonded by the non-reducing adhesive showed the existence of gaps when twisted vigorously, and the adhesive fell off after immersion in water for 30 min. The above results indicate that the eversion of the hydrophobic group leads to a higher adhesive strength of the reduced sericin adhesive to the tissue, further indicating that adjusting the hydrophilic and hydrophobic balance of the adhesive can adjust its underwater adhesive ability.

如图3C-D显示还原丝胶粘合剂对组织的粘合强度达到0.1MPa,而非还原丝胶粘合剂对组织的粘合强度仅为约0.02Mpa;图3E-F显示浸水后还原丝胶粘合剂对组织的粘合强度仍能达到0.05MPa以上,而非还原丝胶粘合剂对组织的粘合剂完全丧失。Figures 3C-D show that the adhesive strength of reduced sericin adhesive to tissue reaches 0.1MPa, while that of non-reduced sericin adhesive to tissue is only about 0.02Mpa; Figures 3E-F show reduced sericin after immersion in water The adhesive strength of the adhesive to the tissue can still reach more than 0.05MPa, while the adhesive of the non-reduced sericin adhesive to the tissue is completely lost.

实施例6丝胶粘合剂对组织渗漏的封堵能力测试Example 6 Test of sealing ability of sericin adhesive to tissue leakage

一、实验过程1. The experimental process

1.准备一段大肠,装入水并将两端系上,用注射器戳一个小孔,水可从小孔身处;1. Prepare a section of large intestine, fill it with water and tie both ends, poke a small hole with a syringe, and the water can pass through the small hole;

2.取粘合剂封堵小孔,观察渗漏情况。2. Take the adhesive to block the small hole and observe the leakage.

二、结果分析2. Analysis of the results

如图3G所示,大肠组织由于穿孔出现渗漏,将还原丝胶粘合剂涂抹在渗漏口部位,按压5s,粘合剂贴在组织表面,同时渗漏被封堵;As shown in Figure 3G, the large intestine tissue leaked due to perforation. Apply reduced sericin adhesive to the leakage port, press for 5s, the adhesive was attached to the surface of the tissue, and the leakage was blocked at the same time;

以上结果说明还原丝胶粘合剂对组织渗漏具有一定的封堵能力。The above results indicate that the reduced sericin adhesive has a certain ability to block tissue leakage.

实施例7丝胶粘合剂动物创面粘合测试Example 7 Animal Wound Adhesion Test of Sericin Adhesive

一、丝胶粘合剂小鼠肝部止血测试1. Hemostasis test of mouse liver with sericin adhesive

如图4中A所示,剪开小鼠腹部皮肤,暴露出肝脏,用生理盐水擦拭干净,将垫有滤纸的培养皿置于肝脏下面,将注射器扎入肝组织,血液流出,将粘合剂涂抹在出血部位,观察伤口出血情况,3M粘合剂组作为对照。As shown in A in Figure 4, cut the abdominal skin of the mouse to expose the liver, wipe it with normal saline, place a petri dish padded with filter paper under the liver, pierce the syringe into the liver tissue, the blood flows out, and the adhesive The agent was smeared on the bleeding site, and the bleeding of the wound was observed, and the 3M adhesive group was used as a control.

二、丝胶粘合剂大鼠创面愈合模型愈合测试2. Healing test of rat wound healing model with sericin adhesive

如图4中D所示,用剪刀在250g左右SD大鼠背部剪开2cm伤口,用医用无菌纱布将周围渗血擦掉,将还原丝胶粘合剂涂抹在表皮侧面,粘合30s,观察创面粘合情况。并继续饲养14天,记录创面愈合情况。以手术缝合的动物和3M粘合剂粘合的动物作为对照。As shown in D in Figure 4, a 2cm wound was cut on the back of a 250g SD rat with scissors, and the surrounding oozing blood was wiped off with sterile medical gauze. Wound adhesion. And continue to raise for 14 days, record the wound healing. Surgically sutured animals and 3M adhesive bonded animals served as controls.

三、丝胶粘合剂对大鼠体内小肠渗漏封堵止血测试3. Sericin adhesive for hemostasis test of small intestinal leakage in rats

如图4中K所示,剪开大鼠腹部皮肤,找到小肠,用医用无菌纱布将周围液体吸尽后,将注射器扎入小肠组织,体液流出,将粘合剂涂抹在出血部位,观察创口体液渗漏情况,不处理组作为阴性对照。As shown in K in Figure 4, cut the abdominal skin of the rat, find the small intestine, use sterile medical gauze to absorb the surrounding liquid, pierce the syringe into the small intestine tissue, the body fluid flows out, apply adhesive to the bleeding site, observe The leakage of body fluids in the wound, the untreated group was used as a negative control.

四、结果分析4. Analysis of results

1.如图4中B、C所示,丝胶粘合剂用于鼠肝损伤出血模型出血时间和出血量明显低于对照,证明丝胶粘合剂具有良好的止血效果,说明材料在内脏器官出血止血方面具有一定作用。1. As shown in B and C in Figure 4, the bleeding time and bleeding volume of the sericin adhesive used in the rat liver injury bleeding model are significantly lower than those of the control, which proves that the sericin adhesive has a good hemostatic effect, indicating that the material bleeds in internal organs Has a certain effect on hemostasis.

2.如图4中E、F所示,丝胶粘合剂用于创面愈合实验,丝胶粘合剂组伤口愈合率与对照组显著高于对照组,图G-J显示,丝胶粘合剂组创面愈合质量较好,有毛囊和皮脂腺和汗腺生成,明显优于对照组。显示出丝胶粘合剂用于创面愈合的优越性。2. As shown in E and F in Figure 4, sericin adhesive was used in the wound healing experiment. The wound healing rate in the sericin adhesive group was significantly higher than that in the control group. Figures G-J show that the sericin adhesive group wound healing. The quality is better, with the generation of hair follicles and sebaceous glands and sweat glands, which is significantly better than the control group. The superiority of sericin adhesive for wound healing is shown.

3.如图4中K、L所示,丝胶粘合剂用于鼠小肠、肝出血渗漏模型具有良好的止血、封堵效果,说明丝胶粘合剂用于小肠、肝出血渗漏方面同样具有一定潜力。3. As shown in K and L in Figure 4, sericin adhesive has good hemostatic and occlusion effects when used in mouse small intestine and liver hemorrhage and leakage models, indicating that sericin adhesive is also used in small intestine and liver bleeding leakage. have some potential.

实施例8丝胶粘合剂体内降解Example 8 In vivo degradation of sericin adhesive

一、实验过程1. The experimental process

1.剪开大鼠背部皮肤,将粘合剂涂抹在背部组织,缝合组织观察7天。1. Cut the skin on the back of the rat, apply adhesive to the back tissue, suture the tissue and observe for 7 days.

2.分别于第3天、第5天、第7天打开伤口,观察粘合剂降解情况。2. The wounds were opened on the 3rd day, the 5th day and the 7th day respectively to observe the degradation of the adhesive.

二、结果分析2. Analysis of the results

如图5A所示,丝胶粘合剂在第三天时被组织包裹,出现一定的炎症反应,第5天粘合剂变小,第7天完全降解,说明丝胶粘合剂在体内具有可降解性。图5B切片染色结果说明粘合剂没有明显的炎症反应和毒性。As shown in Figure 5A, the sericin adhesive was wrapped by tissue on the third day, and there was a certain inflammatory response. The adhesive became smaller on the 5th day, and completely degraded on the 7th day, indicating that the sericin adhesive is degradable in vivo. . Figure 5B section staining results show that the adhesive has no obvious inflammatory response and toxicity.

一、结果分析1. Analysis of the results

如图6B所示,丝胶粘合剂不会导致血细胞破裂,证明丝胶粘合剂具有良好的血液相容性,进一步说明丝胶冻凝胶具有良好的生物相容性。As shown in Fig. 6B, the sericin adhesive did not cause blood cells to rupture, proving that the sericin adhesive has good blood compatibility, further indicating that the sericin jelly has good biocompatibility.

最后应说明的是:以上仅为本发明的优选实例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Finally, it should be noted that the above are only preferred examples of the present invention, and are not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art can still understand the foregoing. The technical solutions described in the embodiments are modified, or some technical features thereof are equivalently replaced. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.

Claims (6)

1.一种丝胶粘合剂的制备方法,包括还原丝胶制备和丝胶粘合剂制备,其特征在于:还原丝胶制备和丝胶粘合剂制备的步骤如下:1. A preparation method of sericin adhesive, comprising preparation of reduced sericin and preparation of sericin adhesive, characterized in that: the steps of preparation of reduced sericin and preparation of sericin adhesive are as follows: 还原丝胶制备:丝胶粉干溶于三(2-羧乙基)膦的4-羟乙基哌嗪乙磺酸缓冲液中还原,获得还原丝胶溶液;Preparation of reduced sericin: sericin powder is dry dissolved in tris(2-carboxyethyl)phosphine and reduced in 4-hydroxyethylpiperazineethanesulfonic acid buffer to obtain reduced sericin solution; 丝胶粘合剂制备:还原丝胶溶液与单宁酸溶液混合,充分反应后获得丝胶粘合剂。Preparation of sericin adhesive: The reduced sericin solution is mixed with the tannic acid solution, and the sericin adhesive is obtained after sufficient reaction. 2.根据权利要求1所述的一种丝胶粘合剂的制备方法,其特征在于:丝胶粉干制备:蚕茧置于Na2CO3溶液,搅拌得胶丝溶液,除杂,透析,冻干。2. The preparation method of a sericin adhesive according to claim 1 , characterized in that: dry preparation of sericin powder: silkworm cocoons are placed in Na2CO3 solution, stirred to obtain glue silk solution, impurity removal, dialysis, freezing Dry. 3.根据权利要求1所述的一种丝胶粘合剂的制备方法,其特征在于:还原丝胶的制备方法如下:3. The preparation method of a sericin adhesive according to claim 1, wherein the preparation method of the reduced sericin is as follows: 4-羟乙基哌嗪乙磺酸缓冲液pH为7.0-7.4;4-Hydroxyethylpiperazine ethanesulfonic acid buffer pH is 7.0-7.4; 三(2-羧乙基)膦以1-30g/mL比例溶于4-羟乙基哌嗪乙磺酸缓冲液;Tris(2-carboxyethyl)phosphine was dissolved in 4-hydroxyethylpiperazine ethanesulfonic acid buffer at a ratio of 1-30g/mL; 丝胶粉干以0.01-0.3g/mL比例溶于三(2-羧乙基)膦溶液。The dry sericin powder is dissolved in tris(2-carboxyethyl)phosphine solution at a ratio of 0.01-0.3 g/mL. 4.根据权利要求1所述的一种丝胶粘合剂的制备方法,其特征在于:丝胶粘合剂的制备方法如下,其中单宁酸溶液制备:单宁酸溶于水中,制成浓度5-50%单宁酸溶液。4. The preparation method of a sericin adhesive according to claim 1, characterized in that: the preparation method of the sericin adhesive is as follows, wherein the tannic acid solution is prepared: the tannic acid is dissolved in water to prepare a concentration of 5 -50% tannic acid solution. 5.根据权利要求1所述的一种丝胶粘合剂的制备方法,其特征在于:丝胶粘合剂的制备方法中还原丝胶溶液、单宁酸溶液按(1-1.5):(1-2)体积比混合。5. The preparation method of a sericin adhesive according to claim 1, characterized in that: in the preparation method of the sericin adhesive, the reduced sericin solution and the tannic acid solution are according to (1-1.5): (1- 2) Volume ratio mixing. 6.一种丝胶粘合剂的应用,其特征在于:丝胶粘合剂在制备止血、创面粘合材料中的应用。6. An application of a sericin adhesive, characterized in that: the application of the sericin adhesive in the preparation of hemostasis and wound surface adhesive materials.
CN202110740024.0A 2021-06-30 2021-06-30 A kind of preparation method and application of sericin adhesive Active CN113398323B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202110740024.0A CN113398323B (en) 2021-06-30 2021-06-30 A kind of preparation method and application of sericin adhesive
PCT/CN2022/098798 WO2023273875A1 (en) 2021-06-30 2022-06-15 Preparation method for sericin adhesive, and use of sericin adhesive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110740024.0A CN113398323B (en) 2021-06-30 2021-06-30 A kind of preparation method and application of sericin adhesive

Publications (2)

Publication Number Publication Date
CN113398323A CN113398323A (en) 2021-09-17
CN113398323B true CN113398323B (en) 2022-05-03

Family

ID=77680532

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110740024.0A Active CN113398323B (en) 2021-06-30 2021-06-30 A kind of preparation method and application of sericin adhesive

Country Status (2)

Country Link
CN (1) CN113398323B (en)
WO (1) WO2023273875A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113398323B (en) * 2021-06-30 2022-05-03 华中科技大学同济医学院附属协和医院 A kind of preparation method and application of sericin adhesive
CN115944773A (en) * 2023-01-03 2023-04-11 中国人民解放军军事科学院军事医学研究院 Bionic high-strength adhesion material based on spidroin and application thereof
CN117005203B (en) * 2023-09-01 2025-07-22 南京大学 Fiber sensor and preparation method thereof
CN117323462B (en) * 2023-09-19 2024-09-03 四川大学 Preparation method and application of injectable adhesive hydrogel, injectable hard tissue adhesive and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106977757A (en) * 2017-04-27 2017-07-25 西南大学 Preparation method of dopamine silk gum laminated film of Nano Silver functionalization and products thereof and application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3772207B2 (en) * 2002-06-19 2006-05-10 独立行政法人農業生物資源研究所 Biodegradable biopolymer material, production method thereof, and functional material comprising the polymer material
KR102251384B1 (en) * 2018-10-02 2021-05-13 한림대학교 산학협력단 Rapid photocuring bio-glue with adhesion, heamostatic and wound healing efficacy
CN109620999A (en) * 2019-01-12 2019-04-16 王若梅 A kind of preparation method of compound hemostatic medical tissue glue
CN111228563A (en) * 2020-01-17 2020-06-05 华南理工大学 Preparation method of silk fibroin and tannic acid composite medical adhesive
CN111905141A (en) * 2020-07-24 2020-11-10 江苏德威兰医疗器械股份有限公司 Solid composition for preparing medical adhesive and medical adhesive prepared from solid composition
CN112006918B (en) * 2020-09-16 2022-03-22 四川大学 Composite material and preparation method and application thereof
CN112226179B (en) * 2020-10-15 2021-06-15 吉林大学 Water-based adhesive and preparation method thereof
CN112843325A (en) * 2021-01-20 2021-05-28 江苏德威兰医疗器械股份有限公司 Medical hydrogel adhesive and preparation method and application thereof
CN113398323B (en) * 2021-06-30 2022-05-03 华中科技大学同济医学院附属协和医院 A kind of preparation method and application of sericin adhesive

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106977757A (en) * 2017-04-27 2017-07-25 西南大学 Preparation method of dopamine silk gum laminated film of Nano Silver functionalization and products thereof and application

Also Published As

Publication number Publication date
WO2023273875A1 (en) 2023-01-05
CN113398323A (en) 2021-09-17

Similar Documents

Publication Publication Date Title
CN113398323B (en) A kind of preparation method and application of sericin adhesive
Xie et al. Wound dressing change facilitated by spraying zinc ions
CN105477678B (en) A kind of new bio adhesive of medical and preparation method thereof
CN115814173B (en) Self-adhesive absorbable biological patch and its preparation method and application
CN113368312B (en) Preparation method and application of biodegradable self-adhesive hydrogel
CN111057252B (en) A kind of strong adhesive hydrogel with controllable removal and preparation method thereof
CN107149700A (en) A kind of three component biological glues and its preparation and application
Kong et al. Tissue adhesives for wound closure
CN104857552B (en) A kind of hemostatic adhesive bandage and preparation method thereof
Zhong et al. Mussel-inspired hydrogels as tissue adhesives for hemostasis with fast-forming and self-healing properties
CN106975097A (en) A kind of bio-medical bonding hydrogel and preparation method thereof
CN115636960B (en) Photo-crosslinking silk fibroin hemostatic adhesive and preparation method thereof
CN111228563A (en) Preparation method of silk fibroin and tannic acid composite medical adhesive
CN110464870B (en) Soft tissue adhesive based on modified collagen and preparation method thereof
CN115233246B (en) A strong collagen bandage material, preparation method and application thereof
CN113563681B (en) Degradable wet-state adhesive hydrogel material and preparation method and application thereof
CN112915261A (en) Preparation method of chemical crosslinking acellular amniotic membrane scaffold
CN112915260A (en) Non-glutaraldehyde cross-linked biomaterial and preparation method thereof
CN115837093B (en) A kind of medical tissue glue and its preparation method and application
Ju et al. A dry double-sided tape post-treated with tannic acid for long-term adhesion in a wet environment
CN118542966A (en) A tissue adhesive and its preparation method and application
CN113599566B (en) A kind of hydrophobic polymer hemostatic repair material, its preparation method and application
CN115845115A (en) Silk protein-based double-layer material and preparation method and application thereof
CN116159192A (en) Injectable hemostatic anti-adhesion hydrogel and preparation method thereof
CN115591007A (en) A preparation method of tissue adhesive for repairing meniscus tear

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant